Skip to content

Guardant Health, Inc.

GH· NasdaqCore metricsCIK 1576280

Medical laboratories28 peers

Last sale
Nov 12, 2026 · +0.06%
Market cap
$20.95B
135.29M shares
Filings
1,086
$360.98M
Q3 2026+32.9% FY25 yoy
-$124.36M
Q3 2026N/M FY25 yoy
-$132.77M
Q3 2026N/M FY25 yoy
-$177.93M
Q3 2026derivedN/M FY25 yoy
-$0.93
Q3 2026N/M FY25 yoy
$1.03B
Q3 2026−28.0% FY25 yoy
$20.95B
—
16.4×
—
-1.11%
—

Twelve months to Sep 30, 2026 · derived

Price

$154.85+58.35%+$57.06past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$982.02MFY 2025
$982.02M0FY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$982,021,000reported
FY 20242024-12-31$739,016,000reported
FY 20232023-12-31$563,948,000reported
FY 20222022-12-31$449,538,000reported
FY 20212021-12-31$373,653,000reported
FY 20202020-12-31$286,730,000reported
FY 20192019-12-31$214,375,000reported
FY 20182018-12-31$90,639,000reported
FY 20172017-12-31$49,842,000reported
FY 20162016-12-31$25,249,000reported

Capital returns

Dividends and buybacks · FY2016 to FY2025
Fiscal yearDividendsBuybacksTotalPer shareSharesShares · yoyof free cash flow
FY2025—$45.01M$45.01M—131.17M sh+6.3%—
FY2024—$0.00$0.00—123.42M sh+1.4%—
FY2023—$0.00$0.00—121.71M sh+18.6%—
FY2020—$0.00$0.00—100.43M sh+6.4%—
FY2019—$0.00$0.00—94.38M sh+10.0%—

Segments

Revenue by Geography, FY2018 to FY2025FY2018United States · FY2018 · $77.92MInternational · FY2018 · $12.72MFY2019United States · FY2019 · $194.31MInternational · FY2019 · $20.06MFY2020United States · FY2020 · $264.66MInternational · FY2020 · $22.07MFY2021United States · FY2021 · $352.56MInternational · FY2021 · $21.09MFY2022United States · FY2022 · $420.62MInternational · FY2022 · $28.92MFY2023United States · FY2023 · $526.52MInternational · FY2023 · $37.42MFY2024United States · FY2024 · $697.16MInternational · FY2024 · $41.85MFY2025United States · FY2025 · $923.28MInternational · FY2025 · $58.74M
LineFY2025ShareChange
United States$923.28M94%+32.4%
International$58.74M6.0%+40.3%
Total$982.02M

From the 10-K filed Feb 19, 2026GH

Medical laboratories

Guardant Health, Inc. is the 6th largest of the 29 covered companies the SEC files under this code, by revenue. SIC 8071

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Guardant Health, Inc. · CIK 1576280 · Engraved from SEC EDGAR